Pathways to Cures: Game-changing IBD Research

This is what is taking place for IBD Researcher's Recent Breakthrough. Within the first year, The CCFA Genetics Initiative had already discovered at least two genetic pathways that are targetable by existing chemicals/drugs - one of which has already proven to be safe in humans. With continued investment into this research and advancement to clinical trials, The CCFA Genetics Initiative is on the cutting edge of changing lives of IBD patients everywhere. A Focus on IBD Research The Crohn's & Colitis Foundation helps fund a number of research studies seeking to identify viable new treatments and ultimately cures for Crohn's disease and ulcerative colitis, the chronic, debilitating diseases known as inflammatory bowel diseases (IBD). Launched in 2012, The CCFA Genetics Initiative is a collaboration of the brightest minds in genetics research. Working together, this team of world-renowned researchers is currently leading the way in breakthrough genetic science related to IBD. Making Huge Strides in Genetics and IBD With an enhanced understanding of the connection between IBD and genetics, we're making huge strides toward new patient treatments and ultimately, the cures for Crohn's disease and ulcerative colitis. Watch our video to learn more about what this research means for the future of IBD. Genetic Pathways and IBD CCFA-supported research has already identified more than 160 genes associated with IBD, but to thoroughly study each gene individually would take years. We have no time to waste - it's time to get focused. To simplify the approach and expedite results, the CCFA Genetics Initiative focuses on "genetic pathway" - groups of genes associated with IBD that act together in the body - and whether these genetic pathways are targetable by therapeutic drugs. Continuing the Investment To fund this science, The Crohn's & Colitis Foundation relies on the generous support of people like you. Every donation helps advance research, supports advocacy on Capitol Hill and helps patients manage their disease. Make your secure online donation today. Get a behind the scenes look at our shoot with Dr. Herbert "Skip" Virgin, Edward Mallinckrodt Professor and Chair of the Department of Pathology and Immunology at the Washington University School of Medicine in Saint Louis, Missouri. Special thanks to Coup Entertainment , who helped bring our research mission to life. Want to learn more about The CCFA Genetics Research Initiative? Access our Media Kit for more information. Or, contact Erin Stoeber at estoeber@ccfa.org (ph: 646.943.758) or Lenora Houseworth at lhouseworth@ccfa.org (ph: 646.943.4415) for more information about this groundbreaking research.